SUZANNE GAZDA M.D. - LONG COVID

SUZANNE GAZDA M.D.

Will we see a rise in neurodegenerative disease post-COVID and post-COVID vaccines?

3/23/2022

As I have discussed in detail in my previous blog in our long COVID series, residual virus is not thought to be the only problem we face relevant to ongoing neurological issues following an infection. Medical News Today reported in a new perspective article, based on clinical observations, autopsies, and lab findings by a team of researchers in Chicago, which argues against the virus directly affecting brain cells. Instead, it appears that the brain is affected by systemic inflammation and circulatory problems.1

Chronic Lyme disease may have lessons about long COVID.

3/3/2022

We recently read an interesting article that detailed some striking similarities between chronic Lyme disease and what clinicians are currently seeing in patients who develop long COVID, also referred to as post-acute COVID 19 syndrome (PACS).1

Long COVID and the brain: what happens when the storm passes?

2/28/2022

While we certainly know more about COVID 19 than we may have when this pandemic first began over two years ago, there is much still to be learned as events continue to evolve and new information comes to light.

The I-RECOVER Management Protocol: more hope for more patients.

2/21/2022

Developed by the notable team of clinicians at the Front Line COVID-19 Critical Care (FLCCC) Alliance, the I-RECOVER protocol was developed in collaboration with expert clinicians including Dr. Paul Marik, Dr. Pierre Kory, Dr. Keith Berkowitz, and others to address the lingering issues associated with long haul COVID syndrome (LHCS).1

A protocol for treatment starts with tamping down inflammation.

2/2/2022

Evolving events mean staying on top of new information as it becomes available or as any recommendations shift.

As we’ve continued to note in our long COVID blog series, increased inflammation and corresponding cytokines, the hallmarks of so many immune-mediated diseases, are clearly also at work in this complex syndrome.

Why does long COVID happen?

1/25/2022

Researchers around the world are racing to uncover the mechanisms behind long COVID, also known as long-hauler COVID, post-acute COVID-19 syndrome (PACS), and LTC-19. This debilitating condition occurs post-infection with SARS-CoV-2 and is described in more detail in our first and second blogs in this special series. Long COVID has elicited great concern in the medical community given its complexity of symptoms, including neurological effects.

The diverse neurological and other symptoms of long COVID.

12/8/2021

As each day brings more anecdotal and research-based data about the continually evolving COVID event, we are also seeing increasing reports of lingering effects that don’t resolve after the initial illness has dissipated. In this second installment of our multi-part long COVID series, we’ll take a closer look at this complex issue and the myriad of issues many patients now face even months post infection.

What is long COVID?

12/1/2021

More than 18 months since COVID-19 was first globally identified, scientists and practitioners in many areas of the medical field are continuing to encounter new insights about this pandemic event. As additional data becomes available, two major things are clear: one, our understanding about the virus is continually evolving and the situation will undoubtedly remain very fluid for some time. And two, the post-infection period does not always resolve within a short or even reasonable amount of time.